Raia Drogasil (OTCMKTS:RADLY) Announces Earnings Results, Hits Estimates

Raia Drogasil (OTCMKTS:RADLY) released its quarterly earnings data on Tuesday. The company reported $0.05 EPS for the quarter, meeting analysts’ consensus estimates of $0.05, Zacks reports. The business had revenue of $2.17 billion during the quarter, compared to analyst estimates of $2.32 billion.

Raia Drogasil Price Performance

Shares of OTCMKTS RADLY opened at $3.77 on Wednesday. The stock’s 50-day simple moving average is $3.56 and its 200-day simple moving average is $4.23. Raia Drogasil has a fifty-two week low of $2.62 and a fifty-two week high of $5.34.

Wall Street Analyst Weigh In

Separately, Zacks Research raised Raia Drogasil to a “hold” rating in a research report on Thursday, April 9th. One research analyst has rated the stock with a Hold rating, According to MarketBeat, the company presently has an average rating of “Hold”.

About Raia Drogasil

Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.

The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.